Arcutis Biotherapeutics ARQT Cash Flow Statement (2019-2026)

NASDAQ ARQT
$32.51 -0.31 (-0.96%)
As of: Oct 21, 2026 · 11:02 AM EDT
Reported Financials

Arcutis Biotherapeutics Quarterly Cash Flow Statement

Periods 30 quarters
Latest Jun 2026

Arcutis Biotherapeutics reported cash from operations of $12.64M and free cash flow of $12.48M for the quarter ended Jun 2026. This cash flow statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-56.98M-71.33M-64.32M-67.41M-107.71M-72.02M-80.10M-70.99M-44.77M-66.28M-35.38M-52.33M-41.54M-10.79M-25.06M-15.89M7.41M17.40M-11.30M15.01M
Depreciation and DepletionDep. & Depletion
0.12M0.18M0.15M0.16M0.16M0.16M0.18M0.20M0.20M0.23M0.17M0.16M0.16M0.15M0.15M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.13M0.19M0.19M0.20M188.00M0.19M0.19M0.20M1.27M0.31M2.98M0.56M0.56M0.56M0.56M0.56M
Amortization of Deferred ChargesAmort. Deferred Charges
0.39M0.40M0.80M
Depreciation & Amortization (CF)Dep. & Amort.
0.12M0.18M0.15M0.16M0.16M0.16M0.18M0.20M0.20M0.23M0.17M0.16M0.16M0.15M0.15M
Share-based CompensationStock Comp.
5.36M5.69M6.53M8.10M8.79M9.26M9.48M10.58M10.00M8.76M10.03M12.52M9.78M9.39M9.78M10.49M10.04M10.06M10.69M12.76M
Gains from Investment SecuritiesGains Investment
-0.85M0.54M0.10M-0.27M-0.15M0.21M
Other non-cash itemsOther Non-Cash
0.08M0.08M0.47M0.48M30.51M1.10M1.08M1.09M1.11M2.73M1.10M0.79M1.29M3.00M0.47M0.73M0.73M0.48M0.68M0.76M
Change in Working Capital
Change in ReceivablesChange Receivables
2.43M6.03M4.31M4.44M2.21M6.39M11.35M5.18M16.61M14.13M12.35M21.27M8.43M31.11M-1.85M10.79M
Change in InventoryChange Inventory
4.31M3.21M1.04M1.92M3.44M-0.78M0.11M0.63M-0.61M0.27M1.95M-0.52M5.89M0.01M14.58M1.18M
Change in Account PayablesChange Payables
2.24M2.39M5.20M-4.03M0.22M0.18M3.38M4.94M-3.97M-1.19M0.99M-5.16M6.51M-0.11M0.31M0.55M-9.29M6.73M5.61M-11.54M
Change in Accured ExpensesChange Accured Exp.
3.37M11.68M-5.53M-1.51M7.62M0.62M-4.46M-5.07M9.20M5.92M-0.33M9.06M10.12M13.18M-0.21M21.23M5.57M23.45M20.77M9.96M
Change in Other Operating AssetsOther Assets Change
-3.69M1.21M-2.06M-0.24M-1.17M2.42M-0.92M8.59M-1.47M-5.54M2.17M4.25M0.07M3.28M-4.30M1.76M1.27M11.73M2.55M
Change in Other Operating LiabilitiesOther Liabilities Change
0.09M-0.02M-0.09M-0.09M-0.11M-0.15M-0.16M-0.16M-0.17M-0.17M-0.18M-0.18M-0.19M-0.19M-0.20M-0.20M-0.15M-0.13M-0.14M-0.14M
Other Working Capital ChangesOther WC Changes
3.78M-1.24M-0.09M1.97M0.13M1.02M-2.58M0.76M-8.76M1.30M5.36M-2.35M-4.44M-0.25M-3.48M4.10M-1.91M-1.39M-11.87M-2.69M
Cash from OperationsCash from Ops.
-40.88M-51.71M-56.98M-61.98M-67.70M-71.07M-80.34M-66.49M-43.98M-56.24M-31.60M-45.12M-34.69M-0.75M-30.38M0.32M-1.75M26.19M2.24M12.64M
Investing Activities
Capital ExpendituresCapex
0.14M0.26M0.12M0.08M0.01M0.12M0.08M0.28M0.06M0.01M0.14M0.61M0.08M0.16M
Change in Property, Plant and EquipmentChange in PP&E
-0.14M-0.26M-0.12M-0.08M-0.01M-0.12M-0.08M-0.28M-0.06M-0.01M-0.14M-0.61M-0.08M-0.16M
Change in IntangiblesChange Intangibless
5.00M
Purchase of InvestmentsInvestments Purchased
32.39M48.24M55.50M80.24M241.56M38.09M39.67M45.61M22.39M118.18M105.95M125.78M5.69M17.40M56.11M33.15M68.54M89.18M62.15M65.59M
Sale and Maturity of InvestmentsInvestments Sold
36.00M72.00M70.93M132.89M67.25M80.41M147.50M135.00M68.00M56.00M77.26M63.64M90.61M57.28M136.94M60.65M43.30M50.82M
Cash from Investing ActivitiesCash from Investing
3.47M23.50M15.30M52.57M-197.26M42.20M107.75M89.12M45.55M-62.19M-28.70M-62.14M84.78M34.88M11.75M17.42M-25.25M-34.18M-11.33M-15.22M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
73.99M
Non-Current Debt
73.99M
Net Debt Issuances and RepaymentsNet Debt Issuance
73.99M
Change in Capital Stock
Common Stock IssuedStock Issued
0.06M0.53M147.72M0.96M0.10M1.07M0.87M96.15M161.76M1.46M0.39M2.59M0.40M1.38M1.48M3.72M1.07M2.99M
Net Shares Issued and RepurchasedNet Shares Issued
0.06M0.53M147.72M0.96M0.10M1.07M0.87M96.15M161.76M1.46M0.39M2.59M0.40M1.38M1.48M3.72M1.07M2.99M
Net Equity Issued and RepurchasedNet Equity Issued
0.06M0.53M147.72M0.96M0.10M1.07M0.87M96.15M161.76M1.46M0.39M2.59M0.40M1.38M1.48M3.72M1.07M2.99M
Other financing activitiesOther financing
-1.64M
Cash from Financing ActivitiesCash from Financing
0.06M72.88M14.72M1.13M284.99M0.96M0.10M1.07M0.87M99.29M161.76M1.46M0.39M-97.41M0.40M1.38M1.48M3.72M1.07M1.99M
Additional items
Exchange Rate EffectFX Effect
-0.05M0.01M-0.08M0.07M-0.07M-0.03M0.10M-0.23M0.00M0.20M-0.10M0.06M-0.12M-0.05M
Change in Cash
-37.35M44.67M-26.96M-8.28M20.03M-27.90M27.46M23.71M2.36M-19.07M101.39M-105.83M50.58M-63.52M-18.23M19.33M-25.62M-4.21M-8.15M-0.64M
Ending Cash Balance
53.32M97.99M71.03M62.75M82.78M54.88M82.33M106.04M108.40M89.32M190.71M84.89M135.47M71.95M53.72M73.05M47.43M43.22M35.07M34.43M
Free Cash FlowFCF
-41.02M-51.97M-57.10M-62.06M-67.70M-71.19M-80.43M-66.76M-44.05M-56.25M-31.60M-45.12M-34.83M-0.75M-30.99M0.25M-1.75M26.19M2.24M12.48M
Net Cash FlowNCF
-37.35M44.67M-26.96M-8.28M20.03M-27.90M27.51M23.70M2.43M-19.14M101.46M-105.80M50.48M-63.28M-18.24M19.13M-25.53M-4.27M-8.03M-0.60M
Interest Paid
6.51M6.51M6.23M2.96M2.57M2.60M2.62M2.54M2.91M3.92M

Arcutis Biotherapeutics Cash Flow Statement API

Pull Arcutis Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ARQT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY